Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma — Masatoshi Kudo (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma
Shared by
Masatoshi Kudo
A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma
Editorial Material
2020
en
Authors
Masatoshi Kudo
Related publications
Editorial Material
2016
Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma
Masatoshi Kudo
Article
2002
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Jordi Bruix
,
Josep M. Llovet
Hepatology
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2021
Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
Masatoshi Kudo
Article
2022
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Masatoshi Kudo
Editorial Material
2018
Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.